The American Academy of Oral Medicine clinical practice statement: dental care for the patient on antiresorptive drug therapy

The American Academy of Oral Medicine (AAOM) affirms that medication-related osteonecrosis of the jaw (MRONJ) is defined as a condition of exposed bone or bone that can be probed through an intraoral or extraoral fistula in the maxillofacial region and that has persisted for more than 8 weeks in patients who are with current or have had previous exposure to antiresorptive or antiangiogenic agents and have no history of radiation therapy of the jaws. The AAOM also affirms that over the years, important information has emerged and can help providers make treatment decisions and minimize the risk for MRONJ.

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2S8uRK5